IONS vs KPTI · rev $514.0M vs rev $68.5M
Ionis Pharmaceuticals Inc (IONS) versus Karyopharm Therapeutics Inc (KPTI) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
IONS currently screens at market cap $12.28B. KPTI currently screens at market cap $205.6M.
Not investment advice. Open the IONS and KPTI stock pages for the full models.
Not investment advice.